ImmunoReagents Revenue and Competitors
Estimated Revenue & Valuation
- ImmunoReagents's estimated annual revenue is currently $2.3M per year.
- ImmunoReagents's estimated revenue per employee is $155,000
Employee Data
- ImmunoReagents has 15 Employees.
- ImmunoReagents grew their employee count by -6% last year.
ImmunoReagents's People
Name | Title | Email/Phone |
---|---|---|
1 | President, CEO | Reveal Email/Phone |
2 | VP and CSO at ImmunoReagents, Inc | Reveal Email/Phone |
ImmunoReagents Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is ImmunoReagents?
We are your worldwide manufacturer of quality polyclonal antibodies used in research and in vitro diagnostics. We have a wide range of secondary antibodies covering a broad spectrum of immunoglobulins from various species and cross absorbed to provide high specificity. We are also your source for primary polyclonal antibodies to hormones, cancer markers, cardiac markers and serum proteins. In addition to our product lines, we offer custom absorptons and purifications to meet specific requirements, yet knowledgeable and experienced to provide bulk manufacturing within cGMP guidelines and ISO quality systems requirements.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | 7% | N/A |
#2 | $1.3M | 15 | -58% | N/A |
#3 | $2.3M | 15 | -25% | N/A |
#4 | $1.3M | 15 | 0% | N/A |
#5 | $2.2M | 15 | 15% | N/A |